Nordea Investment Management
XLRN

Nordea Investment Management’s Acceleron Pharma XLRN Stock Holding History

Nordea Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,848
Closed -$3.29M – 1009
2021
Q3 		$3.29M Buy
18,848
+12,169
+182% +$1.59M ﹤0.01% 657
2021
Q2 		$838K Buy
6,679
+610
+10% +$76.9K ﹤0.01% 837
2021
Q1 		$830K Buy
+6,069
New +$784K ﹤0.01% 799

Nordea Investment Management's XLRN Position: Q4 2021 in Review

Nordea Investment Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 18,848 shares — an estimated $3.29M sold.

Nordea Investment Management first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $3.29M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Nordea Investment Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Nordea Investment Management sold 18,848 Acceleron Pharma shares in Q4 2021, an estimated $3.29M.
  • Nordea Investment Management first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
  • Nordea Investment Management's Acceleron Pharma position peaked at $3.29M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Nordea Investment Management's 13F filing for Q4 2021, filed 20 Jan 2022.